Stay updated with breaking news from Cheri Ackerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Concerto Biosciences today announced the launch of a discovery endeavor to develop a new microbial product for the treatment of vulvovaginal...
/PRNewswire/ -- Concerto Biosciences today announced that Co-founder and CEO Cheri Ackerman has been selected by Ernst & Young LLP (EY US) as an Entrepreneur...
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Harvard Chan–affiliated teams named finalists in President’s Innovation Challenge Two teams with ties to Harvard T.H. Chan School of Public Health are among 25 finalists in the 2021 President’s Innovation Challenge presented by the Harvard Innovation Labs. One of the Harvard Chan–affiliated finalists is Concerto Biosciences, a venture that discovers and develops specific combinations of microbes that, working together, accomplish important functions in human health, agriculture, and industry. The venture was co-founded by Adil Bahalim, DrPH ’20, Bernardo Cervantes, Cheri Ackerman, a...